A Study in Healthy People to Measure How Different Doses of Verducatib Affect the Heart
Clinical trial NCT07760246 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07760246
- Sponsor
- Boehringer Ingelheim
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-17
- Primary completion
- 2026-12-16
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.